Searched for
CHINA S CANSINO BIOLOGICS
China launches a COVID-19 vaccine inhaled through the mouthThe vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated individuals,...- CanSino's inhaled Covid-19 vax gets emergency use nod in ChinaThe inhaled version of Cansino's adenovirus-vectored Covid-19 vaccine has obtained the green light from the National Medical Products Admin...
- WHO clears China's CanSino COVID vaccine for emergency useThe CanSino vaccine uses a harmless virus called an adenovirus to deliver the spike protein of the coronavirus into the body, which then pr...
- Vaccine blood-clot side effect puts focus on immune reactionThe pressure is on for governments that want to hasten immunizing millions of people over the next few months to understand the risk and av...
- CanSinoBIO offered tens of millions of COVID-19 vaccine doses to COVAX: ExecutiveChina has four locally developed COVID-19 vaccines approved for public use and pledged earlier to supply 10 million doses to COVAX without ...
- Pakistan to start importing CanSino COVID-19 vaccine for commercial sale this weekPakistan will begin receiving shipments of China's CanSino Biologics COVID-19 vaccine this week for commercial sale, an official at the com...
- China steps up COVID-19 vaccination, considers differentiated visa policiesThat compared with about 65 million doses administered as of March 14, or an additional 10 million vaccinations in less in a week, as the c...
- China aims to vaccinate 40% of population by end of July: Senior adviserZhong Nanshan, a coronavirus expert who helped shape China's COVID-19 response, said on Monday the current ratio of vaccine doses administe...
- Pakistan approves fourth COVID-19 vaccineChinese company Cansino Biologics Inc's vaccine was approved by the Drug Regulatory Authority of Pakistan (Drap) on Friday.
- Pakistan: China to gift half million doses of Sinopharm vaccine"They have said send your aircraft and airlift this vaccine immediately. So this is a happy bit of news for us, and we will hopefully be su...
- China's COVID-19 vaccine makers apply to join COVAX schemeThe COVAX scheme - led by the World Health Organization and GAVI vaccine alliance - is due to start rolling out vaccines to poor and middle...
- China to vaccinate 50 million people for Lunar New Year - SCMPChina has granted emergency-use status to two candidate vaccines from Sinopharm and one from Sinovac Biotech. It has approved a fourth, fro...
- Fosun Pharma to buy 100 million doses of BioNTech's COVID-19 vaccine for mainland ChinaFosun said it will be entitled to 60% of annual gross profit from sales of doses that it will make from imported bulk ingredients, and 65% ...
- China coronavirus vaccine may be ready for public in November: OfficialChina has four COVID-19 vaccines in the final stage of clinical trials. At least three of those have already been offered to essential work...
- Covid-19 vaccine front-runner held back by China’s spat with CanadaChinese customs hasn’t approved shipments of CanSino’s vaccine to Canada, the National Research Council of Canada said in a Aug. 26 email. ...
- How common cold viruses are being used in vaccines from Russia, ChinaSome researchers believe the strong immune response that caused problems with gene therapy makes these vectors well suited to vaccines, whe...
- Testing of China’s candidate vaccine begins in RussiaThe Ad5-nCoV vaccine already has approval for use by China’s military after early and mid-stage trials, and further late-stage trials are b...
- No country for Chinese vaccine: China's big drug maker not able to conduct overseas trialsIf history is any guide, domestic use-only could be a path for China: An Ebola vaccine, also jointly developed by CanSino and the military ...
- China's CanSino in talks for COVID-19 vaccine Phase III trial overseasChina's success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countri...
- How a Chinese firm jumped to the front of the virus vaccine raceIn May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows...
Load More
